Welcome to the
European Biotechnology Network!
The European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe.
The non-profit organisation brings research groups, universities, SMEs, large companies and indeed all actors in biotechnology together to build and deliver partnerships.
DG Enterprise to take the lead15.09.2014 Jean Claude Juncker, the European Commission President-elect revealed his new Commissioners last week, whilst announcing a change in the units dealing with medicines, medical devices and health technology.The Latest Catch is brought to you by European Biotechnology News
The directorate-general DG Health had previously taken over the lead role from DG Enterprise & Industry. Juncker has now stated that the units will be moved back from DG Health to DG Enterprise & Industry under the newly created responsibility for the Internal Market, Industry, Entrepreneurship and SMEs of Commissioner of Elzbieta Bienkowska. DG Enterprise will take the lead in promoting the pharmaceutical industry and health policy.
More specifically, units SANCO B2 (Health Technology and Cosmetics), SANCO D5 (Medicinal Products – Authorisations, EMA) and SANCO D6 (Medical Products – Quality, Safety and Efficacy) will be moved.
DG Health and Food Safety headed by Vytenis Andriukaitis will have responsibility for food safety watchdog EFSA, the European Centre for Diseases Prevention and Control (ECDC) as well as the European Plant Varieties Office. Commissioner Phil Hogan will be responsible for Agriculture & Rural Development and Carlos Moedas will head Research and Innovation.
During the presentation of his new team, Juncker took a strong stance towards the industry: “We must make use of public funds available at Union level to stimulate private investment in the real economy" he said promising smarter investment, more focus, less regulation and more flexibility in funding. “We must not stifle innovation and competitiveness with too prescriptive and too detailed regulations,” said Juncker, ”notably when it comes to SMEs.”
Our Corporate Members are
European Biotechnology Network
Avenue de Tervueren 13
1040 Brussels, Belgium
Tel: +32 27 33 72 37
Join the European Biotechnology Network!
Individual Membership for natural persons is free, while Corporate Membership, for companies, institutions and research groups start from €500 p.a.